Tralokinumab beneficial for patients with prurigo nodularis-like phenotype atopic dermatitis: JAAD Medha Baranwal4 July 2023 9:15 AM ISTItaly: Tralokinumab, an IL-13 monoclonal antibody, showed clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis...
Crisaborole ointment safe and effective for treating mild to moderate atopic dermatitis Medha Baranwal15 Jun 2023 11:15 AM ISTChina: A recent study in The Journal of Dermatology has shown crisaborole to be safe and well-tolerated for treating patients with mild-to-moderate...
UVB Phototherapy Does Not Increase Risk Of Skin Cancer among Atopic Dermatitis patients Dr. Kamal Kant Kohli14 Jun 2023 6:45 AM ISTUltraviolet B (UVB) phototherapy is a commonly used treatment for patients with atopic dermatitis (AD), a chronic inflammatory skin condition. While...
Adults With Atopic Dermatitis at Increased Risk Of Venous Thromboembolism Dr. Kamal Kant Kohli7 Jun 2023 9:45 AM ISTA recent study published in JAMA Dermatology has shed light on the potential link between atopic dermatitis (AD) and an elevated risk of developing...
Crisaborole effective against atopic dermatitis in Asian patient population Jacinthlyn Sylvia17 May 2023 8:30 PM ISTIn Japanese and Chinese patients with mild to severe atopic dermatitis, crisaborole treatment was efficacious and well tolerated, says an article...
Elevated serum total IgE associated with eczema exacerbation in kids hospitalized for atopic dermatitis Jacinthlyn Sylvia5 May 2023 8:00 PM ISTAtopic dermatitis (AD) can be a debilitating skin condition, often leading to hospitalization due to severe AD exacerbations or infectious...
Tralokinumab safe and effective in treating atopic dermatitis: JAMA Jacinthlyn Sylvia24 April 2023 8:00 PM ISTA new study published in the Journal of American Medical Association suggests that when used to treat adolescents with moderate to severe atopic...
Revisiting Atopic March: Clinical Overview and Treatment Options Dr. Kamal Kant Kohli22 April 2023 11:44 AM ISTAtopic March was first described more than 20 years ago as "the natural history of atopic manifestations, characterized by a typical sequence of...
Dupilumab use in atopic dermatitis patients not associated with cancer development Aditi21 April 2023 8:00 PM ISTNewyork: A 5-year retrospective study published in The Journal of Allergy and Clinical Immunology: In Practice concluded that atopic dermatitis...
Early management of atopic dermatitis can reduce food allergy in infants Aditi12 April 2023 10:00 AM ISTA recent study, "Enhanced early skin treatment for atopic dermatitis in infants reduces food allergy," published in the Journal of Allergy and...
Dupilumab highly effective in reducing symptoms of eczema in children less than 6 years Dr. Kamal Kant Kohli11 April 2023 9:45 AM IST Dupilumab is a monoclonal antibody that targets a key immune pathway in allergies. According to a new study Researchers at Northwestern Medicine have...
Medical Bulletin 7/April/2023 Isra Zaman7 April 2023 3:30 PM ISTHere are the top medical news for the day:Poor sleep may increase genetic susceptibility to asthmaPoor quality sleep may potentially double the risk...
